A detailed history of Yousif Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Yousif Capital Management, LLC holds 279,688 shares of ABT stock, worth $32.9 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
279,688
Previous 281,667 0.7%
Holding current value
$32.9 Million
Previous $29.3 Million 8.95%
% of portfolio
0.36%
Previous 0.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $198,038 - $233,779
-1,979 Reduced 0.7%
279,688 $31.9 Million
Q2 2024

Jul 31, 2024

SELL
$100.73 - $112.44 $340,769 - $380,384
-3,383 Reduced 1.19%
281,667 $29.3 Million
Q1 2024

Apr 26, 2024

BUY
$109.52 - $120.96 $84,878 - $93,744
775 Added 0.27%
285,050 $32.4 Million
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $666,594 - $815,966
-7,391 Reduced 2.53%
284,275 $31.3 Million
Q3 2023

Oct 30, 2023

SELL
$95.53 - $114.62 $666,894 - $800,162
-6,981 Reduced 2.34%
291,666 $28.2 Million
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $479,309 - $534,051
4,756 Added 1.62%
298,647 $32.6 Million
Q1 2023

May 02, 2023

SELL
$96.86 - $114.01 $1.36 Million - $1.6 Million
-14,027 Reduced 4.56%
293,891 $29.8 Million
Q4 2022

Jan 09, 2023

BUY
$95.06 - $111.52 $681,675 - $799,709
7,171 Added 2.38%
307,918 $0
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $414,810 - $480,272
4,287 Added 1.45%
300,747 $29.1 Million
Q2 2022

Aug 01, 2022

SELL
$102.07 - $123.37 $4.24 Million - $5.12 Million
-41,512 Reduced 12.28%
296,460 $32.2 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $296,794 - $361,921
2,603 Added 0.78%
337,972 $40 Million
Q4 2021

Jan 31, 2022

BUY
$115.53 - $141.46 $38.7 Million - $47.4 Million
335,369 New
335,369 $47.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.